China's actions for post-political commitment to global strategy to accelerate cervical cancer elimination

China is among the largest contributors to the global cervical cancer burden. Problems such as insufficient vaccine supply, high vaccine prices, and insufficient policy support hindering vaccine popularization need to be solved.

In the present study, we employed a qualitative research methodology to retrieve and organize policy documents on cervical cancer from 31 provincial and central governments by the documentation method.

The current relevant action program of the Chinese government places strong emphasis on screening and treatment; however, the absence of a consistent national HPV vaccination policy remains the most critical gap in China's strategy to achieve elimination.

Based on the findings of this study, several key recommendations emerge to advance China's political commitment to the Global Strategy to Accelerate the Elimination of Cervical Cancer.